REX-B Trademark

Trademark Overview

On Monday, October 8, 2018, a trademark application was filed for REX-B with the United States Patent and Trademark Office. The USPTO has given the REX-B trademark a serial number of 79250293. The federal status of this trademark filing is REGISTERED as of Tuesday, July 23, 2019. This trademark is owned by DOSENTRX LTD.. The REX-B trademark is filed in the Medical Instrument Products category with the following description:

Medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems
rex-b

General Information

Serial Number79250293
Word MarkREX-B
Filing DateMonday, October 8, 2018
Status700 - REGISTERED
Status DateTuesday, July 23, 2019
Registration Number5809611
Registration DateTuesday, July 23, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2019

Trademark Statements

Goods and ServicesMedical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, January 28, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDOSENTRX LTD.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressIL
Party NameDOSENTRX LTD.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressIL
Party NameDOSENTRX LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIL

Trademark Events

Event DateEvent Description
Friday, February 1, 2019APPLICATION FILING RECEIPT MAILED
Thursday, January 24, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, January 28, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 28, 2019ASSIGNED TO EXAMINER
Saturday, February 2, 2019NON-FINAL ACTION WRITTEN
Sunday, February 3, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, February 11, 2019REFUSAL PROCESSED BY MPU
Monday, February 11, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, March 2, 2019REFUSAL PROCESSED BY IB
Wednesday, March 6, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 6, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 7, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 17, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 7, 2019PUBLISHED FOR OPPOSITION
Tuesday, May 7, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 23, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, October 23, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, November 14, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, December 6, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, July 23, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, November 14, 2019FINAL DISPOSITION PROCESSED
Sunday, March 17, 2019APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

drug delivery devices systems namely monitoring apparatus units dosage measuring